AAAAAA
Results:
1-11
|
Results: 11
Authors:
Barnabe, N
Hasinoff, BB
Citation: N. Barnabe et Bb. Hasinoff, High-throughput fluorescence flow-injection topoisomerase II inhibition assay, J CHROMAT B, 760(2), 2001, pp. 263-269
Authors:
Hasinoff, BB
Chee, GL
Day, BW
Avor, KS
Barnabe, N
Thampatty, P
Yalowich, JC
Citation: Bb. Hasinoff et al., Synthesis and biological activity of a photoaffinity etoposide probe, BIO MED CH, 9(7), 2001, pp. 1765-1771
Authors:
Herman, EH
Zhang, J
Rifai, N
Lipshultz, SE
Hasinoff, BB
Chadwick, DP
Knapton, A
Chai, J
Ferrans, VJ
Citation: Eh. Herman et al., The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin and mitoxantrone-induced cardiotoxicity, CANC CHEMOT, 48(4), 2001, pp. 297-304
Authors:
Hasinoff, BB
Abram, ME
Barnabe, N
Khelifa, T
Allan, WP
Yalowich, JC
Citation: Bb. Hasinoff et al., The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells, MOLEC PHARM, 59(3), 2001, pp. 453-461
Authors:
Hasinoff, BB
Abram, ME
Chee, GL
Huebner, E
Byard, EH
Barnabe, N
Ferrans, VJ
Yu, ZX
Yalowich, JC
Citation: Bb. Hasinoff et al., The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces endopolyploidy in Chinese hamster ovary cells, J PHARM EXP, 295(2), 2000, pp. 474-483
Authors:
Wang, HM
McIntosh, AR
Hasinoff, BB
Rector, ES
Ahmed, N
Nance, DM
Orr, FW
Citation: Hm. Wang et al., B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: A natural hepatic defense against metastasis, CANCER RES, 60(20), 2000, pp. 5862-5869
Authors:
Hasinoff, BB
Chee, GL
Thampatty, P
Allan, WP
Yalowich, JC
Citation: Bb. Hasinoff et al., The cardioprotective and DNA topoisomerase II inhibitory agent dexrazoxane(ICRF-187) antagonizes camptothecin-mediated growth inhibition of Chinese hamster ovary cells by inhibition of DNA synthesis, ANTI-CANC D, 10(1), 1999, pp. 47-54
Authors:
Hasinoff, BB
Aoyama, RG
Citation: Bb. Hasinoff et Rg. Aoyama, Stereoselective metabolism of dexrazoxane (ICRF-187) and levrazoxane (ICRF-186), CHIRALITY, 11(4), 1999, pp. 286-290
Authors:
Iliskovic, N
Hasinoff, BB
Malisza, KL
Li, T
Danelisen, I
Singal, PK
Citation: N. Iliskovic et al., Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy, MOL C BIOCH, 196(1-2), 1999, pp. 43-49
Authors:
Hasinoff, BB
Tran, KT
Citation: Bb. Hasinoff et Kt. Tran, The displacement of iron(III) from its complexes with the anticancer drugspiroxantrone and losoxantrone by the hydrolyzed form of the cardioprotective agent dexrazoxane, J INORG BIO, 77(3-4), 1999, pp. 257-259
Authors:
Hasinoff, BB
Aoyama, RG
Citation: Bb. Hasinoff et Rg. Aoyama, Relative plasma levels of the cardioprotective drug dexrazoxane and its two active ring-opened metabolites in the rat, DRUG META D, 27(2), 1999, pp. 265-268
Risultati:
1-11
|